Skip to main content
VCbacked
Log inGet Started

Precision Neuroscience

New York, United States

Precision Neuroscience is a neural platform that engages in brain-computer interface technology.

$102.0M raised
Dec 2024
Series C
MedicalMedical DeviceNeuroscienceProduct Research

Top Investors

B CapitalAlumni VenturesDraper AssociatesForepont Capital PartnersMubadala Capital Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Precision Neuroscience

How much funding has Precision Neuroscience raised?
Precision Neuroscience has raised $102.0M in total funding. The most recent round was Series C. The last funding was announced in December 2024.
Who are Precision Neuroscience's investors?
Precision Neuroscience's investors include B Capital, Alumni Ventures, Draper Associates, Forepont Capital Partners, Mubadala Capital Ventures.
Where is Precision Neuroscience headquartered?
Precision Neuroscience is headquartered in New York, United States.
What does Precision Neuroscience do?
Precision Neuroscience is a neural platform that engages in brain-computer interface technology.
What stage is Precision Neuroscience at?
Precision Neuroscience is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Precision Neuroscience — Funding & Investors." VCBacked, December 16, 2024, https://www.vcbacked.co/company/precision-neuroscience. Accessed June 3, 2026.
APA
VCBacked. (2024). Precision Neuroscience — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/precision-neuroscience
Wikipedia (cite web)
{{cite web |title=Precision Neuroscience — Funding & Investors |url=https://www.vcbacked.co/company/precision-neuroscience |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Medical

View all
Tempus
Chicago
Sedivention
Munich$848K
Anagram Therapeutics
Boston
ParcelBio
San Francisco$13.2M
LTZ Therapeutics
San Francisco$40.0M
Autoimmunity BioSolutions
Houston$2.0M